29 October 2020
Visiongain has published a new report on Bioprocess Validation Market Report : Forecasts by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End User (Biotechnology & Pharmaceutical Companies). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Bioprocess Validationmarket was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
Validation is a method of building documentary evidence demonstrating a process, activity or procedure, carried out in production or testing maintains the desired level of compliance at all stages. Validation is an action of documenting and demonstrating that any process, procedure, and activity will consistently drive to the required results. It includes the qualifications of equipment and systems.
The global bioprocess validation market is segmented on the basis of process component, test type, end user and geography. The market is segmented into extractable and leachable, integrity testing, microbiology testing. This segment are expected to grow in future.
High demand for outsourcing of bioprocess validation services, stringent safety and quality regulations governing products certifications and testing beyond the biopharmaceutical and pharmaceutical industries in healthcare industry to maintain the agreement with good manufacturing practices are the important factors propelling the growth of this market.
Global bioprocess validation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships,acquisitions and others to increase their footprints in this market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. Some companies profiled in the report include- Merck KGaA (Germany) , SGS S.A.(Switzerland),Erofins Scientific(Luxembourg), Sartorius AG (France), Pall Corporation(US), Cobetter FiltrationEquipment co LTD (China),Toxikon corporation (US) , DOC S.R.L (Italy) , Meissner Filtration Products, INC (US), Thermo Fisher Scientific (US)
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
11 October 2021
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
07 October 2021
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
06 October 2021
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market